多囊卵巢综合征与非多囊卵巢综合征女性的子宫形态与异常:系统综述与Meta分析
该系统综述与Meta分析检索1929篇文献,纳入11项观察性研究共10581名女性,比较多囊卵巢综合征(PCOS)与非PCOS患者的子宫形态及先天性子宮异常患病率。结果显示PCOS与子宫异常患病率较高相关(OR=5.96,95%CI=1.22-29.17,P=0.028),但现有证据质量极低,异质性很高,需进一步研究。
要点
- PCOS与子宫异常患病率较高相关(OR=5.96,95%CI=1.22-29.17,P=0.028)。
- PCOS组子宫畸形总比例为25.0%(95%CI 6.9-43.2),非PCOS组为5.3%(95%CI 0.5-14.8)。
- 现有证据质量极低、异质性很高,需进一步研究确认关联的临床相关性。
核心结论
- 现有极低质量证据显示PCOS与部分子宫异常可能存在关联。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Scopus、Embase和Cochrane Library数据库,无语言或日期限制。
- 纳入11项观察性研究,共10581名女性,比较PCOS与非PCOS患者的子宫形态和异常。
- 采用Mantel-Haenszel随机效应模型计算比值比(OR)和95%CI,使用改良Newcastle-Ottawa量表评估质量。
主要发现
- PCOS与子宫异常患病率较高相关(OR=5.96;95%CI=1.22-29.17,P=0.028)。
- PCOS组子宫畸形总比例为25.0%(95%CI 6.9-43.2,范围0-49%),非PCOS组为5.3%(95%CI 0.5-14.8,范围0-23.1%)。
- 与PCOS可能相关的子宫畸形包括纵隔子宫、双子宫、I形子宫(未被主要分类认可的形态)和畸形子宫,其中纵隔子宫最常报告。
- 子宫尺寸改变包括宫底凹陷深度和角度。
- 研究使用的分类系统包括美国生育协会1988分类(3/11项研究最常用),6项研究未使用任何分类。
关键数值与推荐
- 子宫异常患病率:PCOS组25.0%(95%CI 6.9-43.2)vs 非PCOS组5.3%(95%CI 0.5-14.8)。
- PCOS与子宫异常的关联:OR=5.96(95%CI 1.22-29.17,P=0.028)。
- 评估方法包括2维和3维超声、磁共振成像、子宫输卵管造影、腹腔镜和宫腔镜。
临床怎么用
- 原文未据此给出推荐。
局限性
- 大多数现有研究质量极低,使用不充分的评估方法和分类,易发生高选择偏倚风险。
- PCOS表型及其激素方面的差异研究不足,不能充分解释观察到的变化的病因。
- 纳入研究显示不同程度的异质性,异质性很高。
- 需要进一步研究以确认子宫异常与PCOS的关联是否具有临床相关性。
- 需要进一步研究评估不同激素紊乱(如高雄激素血症)女性中子宫异常患病率是否不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does polycystic ovary syndrome influence the morphology of the uterus and the prevalence of congenital uterine anomalies? SUMMARY ANSWER: Available evidence of very low quality shows a possible association between PCOS and some uterine anomalies. WHAT IS KNOWN ALREADY: Congenital uterine malformations range from subtle changes in uterine shapes to major morphologic deformities It is postulated that major anomalies result from the abnormal development of Mullerian ducts. However, the etiology of minor deformities is a subject of speculation. Many factors may impact the development of the uterus and its morphology in utero and after birth. Many researchers have reported on the increased prevalence of uterine anomalies in PCOS patients, yet the synthesis of evidence has not been performed. STUDY DESIGN, SIZE, DURATION: A systematic review and meta-analysis were performed. We systematically searched the PubMed, Scopus, Embase, and Cochrane Library databases using a complex search strategy including terms such as e.g. 'uterus', 'polycystic ovary syndrome', 'morphology', 'dimensions', 'congenital uterine anomalies', and their synonyms. No language or date restrictions were applied during the literature search. The meta-analysis was based on odds ratio (OR) and 95% CIs using the Mantel-Haenszel random effects model. PARTICIPANTS/MATERIALS, SETTING, METHODS: The primary outcomes included uterine malformations, dimensions, and volume, assessed using non-invasive and invasive methods in observational studies comparing PCOS and non-PCOS patients. We excluded case reports, case series, reviews, studies without control groups, and articles reporting exclusively on polycystic ovary morphology. The modified Newcastle-Ottawa scale was used to assess the quality of the included research. MAIN RESULTS AND THE ROLE OF CHANCE: Our search retrieved 1929 identified publications, 11 of which were included in the systematic review (10 581 women). The majority of the studies were of poor quality. PCOS was associated with higher prevalence of uterine anomalies (OR = 5.96; 95% CI = 1.22-29.17, P = 0.028). The general count of uterine malformations was significantly higher in the PCOS group (25.0%, 95% CI 6.9-43.2, range 0-49%) than in the non-PCOS group (5.3%, 95% CI 0.5-14.8, range 0-23.1%). The studies had a very high heterogeneity. The scope of uterine malformations possibly linked to PCOS included septate, didelphys, I-shaped (morphology that is not recognized by any main classifications), and dysmorphic uteri. The septate uterus was the most often reported malformation. Altered dimensions included fundal indentation depth and angle. Available research used four classification systems: the most frequently reported was that of the American Fertility Society 1988 (3/11). Six studies did not use any classification. The assessment methods included 2- and 3-dimensional ultrasound, magnetic resonance imagining, hysterosalpingography, laparoscopy, and hysteroscopy. LIMITATIONS, REASONS FOR CAUTION: Most of the available studies are of very low quality, use inadequate assessment methods and classifications, and are prone to a high risk of selection bias. Additionally, the differences between PCOS phenotypes and their hormonal aspects are poorly addressed and do not sufficiently explain the etiology of observed changes. The included research displays a varying level of heterogeneity. WIDER IMPLICATIONS OF THE FINDINGS: Further research is needed to (i) confirm whether the association between uterine anomalies and PCOS is clinically relevant, (ii) evaluate whether the prevalence of the uterine anomalies varies between women with different hormonal disturbances (e.g. hyperandrogenism), (iii) assess the benefit of any intervention for uterine anomalies in women with PCOS. STUDY FUNDING/COMPETING INTEREST(S): This study received no funding. The authors have no conflicts to disclose. REGISTRATION NUMBER: CRD42024527964; http://www.crd.york.ac.uk/prospero/.
引用
- Zaborowska L, Blok J, Ludwin I, et al. Uterine morphology and anomalies in women with and without polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2025. PMID: 40578330. doi:10.1093/humrep/deaf117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。